Quantum BioPharma Ltd.

CNSX:QNTM Stock Report

Market Cap: CA$47.0m

Quantum BioPharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

CNSX:QNTM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
26 Nov 25SellCA$349,376Donal CarrollIndividual34,467CA$13.80
21 Nov 25SellCA$511,833Donal CarrollIndividual56,445CA$10.91
07 Aug 25BuyCA$10,937Zeeshan SaeedIndividual300CA$36.46
17 Jul 25BuyCA$21,893Anthony DurkaczIndividual700CA$31.28
14 Jul 25BuyCA$14,608Donal CarrollIndividual500CA$29.22
23 Jun 25BuyCA$1,106,031Malone Wealth Ventures LLCCompany33,465CA$40.08
20 Jun 25BuyCA$2,245,714Malone Wealth Ventures LLCCompany43,498CA$51.63
11 Jun 25BuyCA$995,093Malone Wealth Ventures LLCCompany38,214CA$26.04

Insider Trading Volume

Insider Buying: QNTM insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of QNTM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders237,1536.21%
Institutions889,83523.3%
General Public2,690,00070.5%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 98.1%.

Top Shareholders

Top 24 shareholders own 29.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
21.7%
Malone Wealth Ventures LLC
829,730CA$10.2m35.9%no data
3.28%
Zeeshan Saeed
125,214CA$1.5m0.01%no data
1.35%
Terrence Lynch
51,417CA$633.5k0%no data
0.98%
AdvisorShares Investments, LLC
37,237CA$458.8k0.67%0.03%
0.81%
Anthony Durkacz
30,767CA$379.0k-71.6%no data
0.77%
Lakshmi Kotra
29,573CA$364.3k0%no data
0.23%
UBS Asset Management AG
8,754CA$107.8k-80.9%no data
0.15%
First Republic Capital Corp.
5,749CA$70.8k0%100.0%
0.081%
Steward Partners Investment Advisory, LLC
3,100CA$38.2k0%no data
0.067%
Morgan Stanley
2,564CA$31.6k1,860%no data
0.019%
JPMorgan Chase & Co.
736CA$9.1k-18%no data
0.018%
Osaic Wealth, Inc.
680CA$8.4k750%no data
0.015%
RBC Dominion Securities Inc.
583CA$7.2k611%no data
0.0066%
Cetera Trust Company, N.A.
250CA$3.1k0%no data
0.0041%
SBI Holdings, Inc.
155CA$1.9k0%no data
0.0038%
Adnan Bashir
144CA$1.8k0%no data
0.0026%
Merrill Lynch, Pierce, Fenner & Smith Incorporated
100CA$1.2k-98.3%no data
0.0024%
Fédération des caisses Desjardins du Québec
92CA$1.1k229%no data
0.001%
Nathan Coyle
38CA$470.3-98.5%no data
0.00089%
Group One Trading LLC
34CA$418.50%no data
0.00079%
Rockefeller & Co. LLC
30CA$371.50%no data
0.00063%
National Bank Investments Inc.
24CA$296.30%no data
0.00039%
Activest Wealth Management, LLC
15CA$183.40%no data
0.00005%
The Toronto-Dominion Bank
2CA$23.5-33.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/22 08:57
End of Day Share Price 2025/12/18 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Quantum BioPharma Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kumaraguru RajaBrookline Capital Markets
Karen SterlingKingswood Capital